Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells

Summary. We used two indirect approaches [image analysis (Feulgen staining) and fluorescence in situ hybridization (FISH)] to study bone marrow plasma cells (BMPC) in 28 patients fulfilling criteria for MGUS. 61% of patients were found to be aneuploid after image analysis: three were hypodiploid and 14 were hyperdiploid. 12/14 hyperdiploid patients also revealed abnormalities after FISH: 12‐72% of BMPC exhibited trisomy for at least one of chromosomes 3, 7, 9 and 11. These latter chromosomes are the four chromosomes most frequently implicated (in the shape of trisomy) in MM, confirming the tight relationship between both conditions. After a median follow‐up of 19 months (12‐41 months) no patient developed overt MM. Also, we failed to find any relationship between currently available biological parameters and DNA findings. As literature data give a transformation rate of 20‐30% after a follow‐up of 20‐35 years, it is worth presuming that some aneuploid patients will evolve to MM, whereas others (also with aneuploid bone marrow plasma cells) will never develop cancer. Our findings indicate that numeric abnormalities, as they are shared both by MGUS and MM patients, are certainly an additional or a prerequisite event, but are not related to an overt disease. They also emphasize the importance of cytogenetic study in the pathophysiology of MGUS.

[1]  R. Kyle Monoclonal gammopathy of undetermined significance (MGUS). , 1995, Bailliere's clinical haematology.

[2]  F. Bauters,et al.  CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance. , 1995, Journal of clinical pathology.

[3]  J. Mary,et al.  Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. , 1995, Blood.

[4]  F. Davey,et al.  Applications of in situ hybridization in the study of hematologic malignancies. , 1994, Hematology/oncology clinics of North America.

[5]  F. Bauters,et al.  Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study. , 1994, Cancer genetics and cytogenetics.

[6]  R. Berger,et al.  Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. , 1993, Leukemia.

[7]  R A Kyle,et al.  "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up. , 1993, Mayo Clinic proceedings.

[8]  B. Durie Cellular and molecular genetic features of myeloma and related disorders. , 1992, Hematology/oncology clinics of North America.

[9]  B. Barlogie,et al.  Plasma cell myeloma--new biological insights and advances in therapy. , 1989, Blood.

[10]  C. Turc‐Carel,et al.  The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology , 1987, Cancer.

[11]  M. Vicariot,et al.  Monoclonal gammopathies in the adult population of Finistère, France. , 1982, Journal of clinical pathology.

[12]  B. Barlogie,et al.  Ploidy and proliferative characteristics in monoclonal gammopathies. , 1982, Blood.

[13]  L. Elveback,et al.  Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. , 1972, Blood.